TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 12 filers reported holding TRANSCODE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9 | – | 12,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| One68 Global Capital, LLC | 30,120 | $10,196 | 0.02% |
| SHEETS SMITH WEALTH MANAGEMENT | 60,000 | $20,310 | 0.00% |
| Warberg Asset Management LLC | 20,000 | $6,770 | 0.00% |
| Shay Capital LLC | 15,060 | $5,098 | 0.00% |
| WELLS FARGO & COMPANY/MN | 51 | $17 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 75,683 | $25,641 | 0.00% |
| STATE STREET CORP | 21,019 | $7,121 | 0.00% |
| GOLDMAN SACHS GROUP INC | 13,122 | $4,442 | 0.00% |
| BlackRock Inc. | 1,385 | $469 | 0.00% |